Ads
related to: psoriasis treatment- Request A Representative
Request A Rep To Provide Info About
A PSO Biologic Treatment Option.
- Access HCP Resources
Get Support For Your Patients By
Downloading Forms And Resources.
- Find Dosing & Admin Info
Learn About Loading And Maintenance
Doses For A Psoriasis Treatment.
- View Patient Testimonials
Watch A Biologic-Experienced
Patient Testimonial Video.
- A Different Anti-TNF
Discover The Molecular Structure Of
Fab' Biologic. Watch An MOA Video.
- Get Safety Profile Info
Learn About The Safety Of A
Plaque Psoriasis Injection Option.
- Request A Representative
Search results
Rosacea is strongly associated with melanoma in Caucasians - Scientific Reports
Nature· 3 days agoRosacea is often considered a cosmetic problem but is known to be associated with a variety of comorbidities. To identify such risks, we generated two age- and sex-matched real-world cohorts ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 3 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Are Saunas Good for Your Skin? Discover How Women Over 50 Can Sweat Their Way to a More Radiant,...
Fort Worth Star-Telegram· 6 days agoRelax and rejuvenate in no time!
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 3 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...
Howard W. Robin Sells 16,650 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 6 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of the company’s stock in a transaction on Friday, May 17th. Following the completion of the transaction ...
Swiss National Bank Cuts Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
ETF DAILY NEWS· 3 days agoSwiss National Bank trimmed its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form ...
Jonathan Zalevsky Sells 7,355 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 6 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 7,355 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average ...